Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-05 · accession 0001628280-23-011061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-06 | 2023-04-05 | SKIN | Stanleick Andrew Roy | CEO, Dir | A - Grant | — | +294.6K | 686.4K | +75% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-05 | A | A | 294,579 | — | 686,448 | D | — | — | (F1) Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. |